Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Hoffmann-la Roche Drug Patent Portfolio

Hoffmann-la Roche owns 1 orange book drug protected by 5 US patents Given below is the list of Hoffmann-la Roche's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10350214 Preparation containing tetracyclic compound at high dose 24 Apr, 2035
Active
US11433076 Preparation containing tetracyclic compound at high dose 24 Apr, 2035
Active
US9365514 Composition comprising tetracyclic compound 04 Mar, 2032
Active
US9126931 Tetracyclic compound 29 May, 2031
Active
US9440922 Tetracyclic compound 09 Jun, 2030
Active


Given below is the list of recent legal activities going on the following drug patents of Hoffmann-la Roche.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 28 Feb, 2024 US9440922
Payment of Maintenance Fee, 8th Year, Large Entity 29 Nov, 2023 US9365514
Payment of Maintenance Fee, 8th Year, Large Entity 02 Mar, 2023 US9126931
Payment of Maintenance Fee, 4th Year, Large Entity 06 Jan, 2023 US10350214
Recordation of Patent Grant Mailed
Critical
06 Sep, 2022 US11433076
Patent Issue Date Used in PTA Calculation
Critical
06 Sep, 2022 US11433076
Email Notification
Critical
18 Aug, 2022 US11433076
Issue Notification Mailed
Critical
17 Aug, 2022 US11433076
Dispatch to FDC 05 Aug, 2022 US11433076
Email Notification
Critical
03 Aug, 2022 US11433076
Mailing Corrected Notice of Allowability 03 Aug, 2022 US11433076
Corrected Notice of Allowability 29 Jul, 2022 US11433076
Information Disclosure Statement considered
Critical
29 Jul, 2022 US11433076
Pubs Case Remand to TC
Critical
29 Jul, 2022 US11433076
Workflow - Request for RCE - Finish 28 Jul, 2022 US11433076


Hoffmann-la Roche's Family Patents

Hoffmann-la Roche drugs have patent protection in a total of 38 countries. It's US patent count contributes only to 12.5% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Hoffmann-la Roche Drug List

Given below is the complete list of Hoffmann-la Roche's drugs and the patents protecting them.


1. Alecensa

Alecensa is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10350214 Preparation containing tetracyclic compound at high dose 24 Apr, 2035
(10 years from now)
Active
US11433076 Preparation containing tetracyclic compound at high dose 24 Apr, 2035
(10 years from now)
Active
US9365514 Composition comprising tetracyclic compound 04 Mar, 2032
(7 years from now)
Active
US9126931 Tetracyclic compound 29 May, 2031
(6 years from now)
Active
US9440922 Tetracyclic compound 09 Jun, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alecensa's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List